NanoRepro AG Logo

NanoRepro AG (NN6)

XETR

Currency in EUR
1.91
+0.02 (+1.33%)

Real-time Data

07:00 AM

Day's Range

1.91
1.91

52 wk Range

1.31
2.40

Overview - NN6 - NanoRepro AG

Key Statistics

Valuation

Enterprise Value

16.32M

P/E (Trailing)

‪7.39‬

P/E (Forward)

‪47.75‬

PEG Ratio

‪47.75‬

Price / Sales (TTM)

‪5.55‬

Price / Book

‪0.66‬

EV / EBITDA

‪-7.97‬

Profitability

Profit Margin

‪-45.83%‬

Operating Margin

‪-60.04%‬

Return on Assets

‪-3.42%‬

Return on Equity

‪-5.34%‬

Ownership

Shares Outstanding

12.61M

Held by Insiders

‪2.00%‬

Held by Institutions

‪8.94%‬

Price stats

Beta

‪0.46‬

50-Day Avg

‪2.04‬

200-Day Avg

‪1.67‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

2 analysts

Average price target

‪€ 4.45‬

Market Cap - NN6 - NanoRepro AG

Peers - NN6 - NanoRepro AG

Peer Comparison

Compared with companies in Diagnostics & Research listed on XETR.

Profile Summary - NN6 - NanoRepro AG

About

NanoRepro AG is a biotechnology company that specializes in the development, manufacturing, and distribution of rapid diagnostic tests. These tests are primarily used in personal and home care health sectors. NanoRepro's portfolio includes products that target infectious diseases, fertility monitoring, and preventive…

SectorHealthcare
IndustryDiagnostics & Research
Employees22
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.